Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Linus Pauling and sickle cell disease.

William A Eaton1

  • 1Laboratory of Chemical Physics, Building 5, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0520, USA. eaton@helix.nih.gov

Biophysical Chemistry
|March 21, 2003
PubMed
Summary

Linus Pauling's 1949 discovery identified sickle cell anemia as the first molecular disease, revolutionizing medicine. This retrospective honors that foundational work in molecular pathology and hemoglobin research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease.

Blood. Red cells & iron·2026
Same author

Pyruvate kinase deficiency modifies sickle hemoglobin carrier and sickle cell disease phenotypes in mice.

JCI insight·2026
Same author

Comparative analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model.

Blood advances·2025
Same author

Therapeutic potential of the latest oxygen affinity-modifying agent, GBT021601, for treating sickle cell disease is questionable.

British journal of haematology·2024
Same author

Functional and multi-omics signatures of mitapivat efficacy upon activation of pyruvate kinase in red blood cells from patients with sickle cell disease.

Haematologica·2024
Same author

In vivo measurement of RBC survival in patients with sickle cell disease before or after hematopoietic stem cell transplantation.

Blood advances·2024

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medical History

Background:

  • Retrospective analysis of Linus Pauling et al.'s seminal 1949 paper.
  • Exploration of sickle cell anemia as the first identified molecular disease.
  • Influence of John Edsall's work on hemoglobin research history.

Discussion:

  • Impact of Pauling's discovery on understanding genetic diseases.
  • Significance of identifying a disease at the molecular level.
  • Connection between molecular pathology and clinical medicine.

Key Insights:

  • Sickle cell anemia established the concept of molecular diseases.
  • Pauling's research marked a paradigm shift in biology and medicine.
  • Historical context provided by Edsall's contributions.

Related Experiment Videos

Outlook:

  • Continuing legacy of molecular disease research.
  • Future directions in understanding genetic disorders.
  • Importance of historical perspectives in scientific advancement.